# Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder

> **NCT00903045** · PHASE4 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 264 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Propiverine hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00903045
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 264 (ACTUAL)
- **Last updated:** 2009-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00903045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00903045, "Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00903045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*